Concerns with GLP-1 Supply (Tirzepatide and Semaglutide)

Tirzepatide:

Update: 3/19/2025

Immediate Call to Action: Last Shipment of Tirzepatide Available!

We have been working hard with our suppliers to secure one last order of Tirzepatide…

Today, we have received our final shipment of Tirzepatide 20mg/ml x 3ml vials, with an expiration date of 10/30/2025. This is a limited supply, and vials will be available on a first come, first serve basis.

Product Details:

• Tirzepatide 20mg/ml X 3ml (60mg)
  • Vitality Member Pricing:
    • 1 vial = $760ea
    • 2 vials = $1400
    • 3 vials = $2100
  • Non-Member Pricing:
    • 1 vial = $778ea
    • 2 vials = $1418
    • 3 vials = $2127

Act Fast—These Won’t Last!

Due to a significant increase in demand, our team is working diligently to keep you informed about your order status. Please be patient as response times may be longer than usual. To Reserve Your Vials: Please email us at refills@mynextgenrx.com as soon as possible. In your email, include:

• Your full name
• Date of birth
• Pharmacy location (Tulsa or Broken Arrow)
• Best contact phone number
• Number of vials you wish to reserve

Important: Prepayment will be required for these prescriptions.

Thank you for your understanding and cooperation during this time. We are here to support you and will keep you updated on any further developments. Don’t miss out—act today!

Date: 03/06/2025

On March 5th, 2025, the judge overseeing the OFA v. FDA denied the plaintiff’s request for a preliminary injunction to allow for compounded Tirzepatide, which means that, as it stands, the FDA's enforcement discretion will remain in effect until March 19th, 2025. However, there is a possibility that the OFA may appeal this ruling, which could impact the timeline for dispensing.

As a result, it appears that NextGenRx will not be able to dispense Tirzepatide after March 19th, 2025. We strongly recommend that you prepare for this stoppage by securing your medication refill as soon as possible (no later than: 3/13/2025).

What This Means for Our Customers:

1. Immediate Action Required: We urge all patients to submit their refill request for Tirzepatide formulations immediately. Given the uncertainty surrounding the appeal process, it is crucial to act quickly.
2. Order Fulfillment Timeline: Please note that we will not be able to refill orders for Tirzepatide after March 19th, 2025, unless we receive further updates from the courts.
3. Increased Demand: Our team is experiencing a significant increase in demand, and while we are committed to keeping you informed about your order status and addressing any specific questions, please be patient as response times may be longer than usual. To reserve the number of vials you would like to refill, please email us at refills@mynextgenrx.com as soon as possible. In your email, include your full name, date of birth, pharmacy location (Tulsa or Broken Arrow), best contact phone number, and the number of vials you wish to reserve. Please remember that prepayment will be required for these prescriptions.

Thank you for your understanding and cooperation during this time. We are here to support you and will keep you updated on any further developments.

Date: 02/11/2025

On 02/11/2025 the FDA clarified their position on their intentions for enforcement discretion relating to the dispensing of Tirzepatide containing compounded injectables to allow dispensing until either 03/19/2025 or until the date of the district court’s decision on the plaintiffs’ preliminary injunction motion in OFA v. FDA whichever is longer. As such, NextGenRx will continue to dispense Tirzepatide containing compounded injectable medications until the later of 03/19/2025 or a date to be determined by the courts.

Our recommendation for you is to secure as much medication as feasible for you by ordering a refill of the number of vials you and your physician approve of by March 11th, 2025. We will likely be supplying these medications beyond this 03/19/2025, however, we are all at the mercy of the courts.

To better serve you, please email: refills@mynextgenrx.com to reserve the number of vials you would like to refill as soon as possible. In your email please provide: full name, date of birth, pharmacy location (Tulsa or Broken Arrow), best contact phone number and the number of vials you would like to reserve. We will require prepayment of these prescriptions.

Date: 12/19/2024

On 12/19/24 the FDA removed the brand name drugs: Mounjaro and Zepbound from the drug shortage list. As such, NextGenRx can dispense the compounded version: Tirzepatide until 3/19/2025. Our supplier would like us to provide them with an estimate of how many vials we would like to purchase.

To better serve you, please email: refills@mynextgenrx.com to reserve the number of vials you would like to refill as soon as possible. In your email please provide: Name, date of birth, best contact phone number and the number of vials you would like to reserve. We will require prepayment of these prescriptions.

Semaglutide:

Date: 03/19/2025

We want to inform you that the last day for compounding Semaglutide injections will be 05/22/2025. To help you save money while “stocking up” on your supply of this medication, we have been working closely with our suppliers.

We are excited to announce that we have ordered a higher concentration of Semaglutide at 5mg/ml in a 4ml vial. While we will continue to offer the Semaglutide 2.5mg/ml (available in both 2ml and 4ml vials), we highly recommend considering the higher concentration for better value.

Pricing Details:

• Semaglutide 2.5mg/ml – 2ml vial
  • #1 Vial = $248 (Vitality: $230)
• Semaglutide 2.5mg/ml – 4ml vial
  • #1 Vial = $348 (Vitality: $330)
  • #2 Vials = $648 (Vitality: $630)
• Semaglutide 5mg/ml – 4ml vial (Best Value)
  • #1 Vial = $608 (Vitality: $590) Savings of $40 compared to purchasing two of the lower strength vials.
  • #2 Vials = $1,108 (Vitality: $1,090)

To best serve you, please continue to order refills of your Semaglutide as you normally do until April 15th, 2025. After this date, we encourage you to consider “stocking up” on your Semaglutide injectable prescriptions. To reserve the number of vials you would like, please email us at refills@mynextgenrx.com. In your email, include your full name, date of birth, pharmacy location (Tulsa or Broken Arrow), best contact phone number, and the number of vials you wish to reserve. Please note that prepayment will be required for these prescriptions.

Our current supply of Semaglutide has an expiration date in January of 2026, so don’t miss out on this opportunity!

Thank you for your continued trust in NextGenRx. We are here to support you!

Date: 02/21/2025

On 02/21/2025 the FDA removed the brand name drugs: Ozempic and Wegovy from the drug shortage list. As such, NextGenRx can dispense the compounded version: Semaglutide until 05/22/2025. Our supplier would like us to provide them with an estimate of how many vials we would like to purchase. To best serve you, please continue to order refills of your semaglutide as you usually do until April 15th, 2025.

On or after April 15th, 2025, please consider “stocking up” on your semaglutide injectable prescriptions by sending us an email to: refills@mynextgenrx.com to reserve the number of vials you would like. In your email please provide: full name, date of birth, pharmacy location (Tulsa or Broken Arrow), best contact phone number, and the number of vials you would like to reserve. We will require prepayment of these prescriptions.